Complete Lifestyle Medicine Intervention Program
Conditions: High Cholesterol; Diabetes; Obesity; Hypertension; Heart Diseases Interventions: Behavioral: Lifestyle Medicine Sponsors: Northern Ontario School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Effectiveness of peer-led intervention in control of non-communicable diseases in rural areas of Khordha district: study protocol for a cluster randomized controlled trial
This study aims to evaluate the effectiveness of peer-led intervention compared to standard care in achieving control of selected non-communicable diseases (NCDs) in Indian context at 1 year of intervention among people of 30 –60 years with hypertension and/or diabetes mellitus and/or dyslipidaemia.MethodsA cluster-randomized controlled trial will be conducted in villages of two rural blocks of the Khordha district of Odisha from August 2023 to December 2024. A total of 720 eligible participants (360 in the intervention group and 360 in the control group) will be recruited and randomized into two study arms. The particip...
Source: Trials - January 3, 2024 Category: Research Source Type: clinical trials
Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients
Conditions: Celiac Disease Interventions: Dietary Supplement: LP-LDL Probiotic; Dietary Supplement: Placebo Comparator Sponsors: University of Roehampton Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
Conditions: Acute Metabolic Effects of Evolocumab and Atorvastatin Interventions: Drug: Evolocumab Sponsors: Region Stockholm; Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: Statins; Drug: Evolocumab Sponsors: Xuanwu Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
A Clinical Study on the Effectiveness of a Lacticaseibacillus Strain on Blood Cholesterol Levels
Conditions: Cholesterol Levels Interventions: Other: Lacticaseibacillus with oats; Other: Plain oats Sponsors: Democritus University of Thrace Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Interventions: Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); Sponsors: Peking University People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Conditions: Acute Coronary Syndrome; Non ST Segment Elevation Acute Coronary Syndrome Interventions: Drug: Tafolecimab; Drug: Cholesterol Absorption Inhibitor; Drug: Statin Sponsors: China National Center for Cardiovascular Diseases; Innovent Biologics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: Atorvastatin; Drug: Rosuvastatin; Other: No drugs Sponsors: Pomeranian Medical University Szczecin Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
Conditions: Intracranial Atherosclerosis; Atherosclerotic Plaque; Stenosis Interventions: Drug: Alirocumab; Drug: Atorvastatin Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
Condition: Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Interventions: Drug: Alirocumab; Drug: Atorvastatin Sponsor: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
Conditions: Stroke; Intracranial Atherosclerotic Stenosis Interventions: Drug: Alirocumab; Drug: Atorvastatin Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
